278 related articles for article (PubMed ID: 18668543)
1. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes.
Cillero-Pastor B; Caramés B; Lires-Deán M; Vaamonde-García C; Blanco FJ; López-Armada MJ
Arthritis Rheum; 2008 Aug; 58(8):2409-19. PubMed ID: 18668543
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes.
Vaamonde-García C; Riveiro-Naveira RR; Valcárcel-Ares MN; Hermida-Carballo L; Blanco FJ; López-Armada MJ
Arthritis Rheum; 2012 Sep; 64(9):2927-36. PubMed ID: 22549761
[TBL] [Abstract][Full Text] [Related]
3. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes.
Roman-Blas JA; Contreras-Blasco MA; Largo R; Alvarez-Soria MA; Castañeda S; Herrero-Beaumont G
Eur J Pharmacol; 2009 Nov; 623(1-3):125-31. PubMed ID: 19765584
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytes.
Valcárcel-Ares MN; Riveiro-Naveira RR; Vaamonde-García C; Loureiro J; Hermida-Carballo L; Blanco FJ; López-Armada MJ
Rheumatology (Oxford); 2014 Jul; 53(7):1332-43. PubMed ID: 24609059
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in osteoarthritis.
Blanco FJ; López-Armada MJ; Maneiro E
Mitochondrion; 2004 Sep; 4(5-6):715-28. PubMed ID: 16120427
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB; Lerner UH
Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
10. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production.
Dave M; Attur M; Palmer G; Al-Mussawir HE; Kennish L; Patel J; Abramson SB
Arthritis Rheum; 2008 Sep; 58(9):2786-97. PubMed ID: 18759268
[TBL] [Abstract][Full Text] [Related]
11. The complex pathology of osteoarthritis: even mitochondria are involved.
Roach HI
Arthritis Rheum; 2008 Aug; 58(8):2217-8. PubMed ID: 18668573
[No Abstract] [Full Text] [Related]
12. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.
Chabane N; Zayed N; Afif H; Mfuna-Endam L; Benderdour M; Boileau C; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Osteoarthritis Cartilage; 2008 Oct; 16(10):1267-74. PubMed ID: 18417374
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils.
Vega A; Chacón P; Alba G; El Bekay R; Martín-Nieto J; Sobrino F
J Leukoc Biol; 2006 Jul; 80(1):152-63. PubMed ID: 16624933
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization.
Johnson K; Jung A; Murphy A; Andreyev A; Dykens J; Terkeltaub R
Arthritis Rheum; 2000 Jul; 43(7):1560-70. PubMed ID: 10902761
[TBL] [Abstract][Full Text] [Related]
15. (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14-hexadecatetraen-1-ol (Plaunotol) increases cyclooxygenase-2 expression via nuclear factor kappaB and cyclic AMP response element in rat gastric epithelial cells.
Fu Hy; Yabe Y; Asahi K; Hayashi Y; Murata H; Eguchi H; Tsujii M; Tsuji S; Kawano S
Eur J Pharmacol; 2005 Nov; 524(1-3):38-43. PubMed ID: 16253229
[TBL] [Abstract][Full Text] [Related]
16. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation.
Shin KM; Shen L; Park SJ; Jeong JH; Lee KT
J Pharm Pharmacol; 2009 Apr; 61(4):479-86. PubMed ID: 19298695
[TBL] [Abstract][Full Text] [Related]
17. Counteracting effect of TRPC1-associated Ca2+ influx on TNF-α-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts.
Hai L; Kawarabayashi Y; Imai Y; Honda A; Inoue R
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G356-67. PubMed ID: 21546578
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced prostaglandin E2 production and cyclooxygenase-2 expression in dental pulp cells: downstream calcium signalling via activation of prostaglandin EP receptor.
Chang MC; Chen YJ; Tai TF; Tai MR; Li MY; Tsai YL; Lan WH; Wang YL; Jeng JH
Int Endod J; 2006 Oct; 39(10):819-26. PubMed ID: 16948668
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate.
Heinecke LF; Grzanna MW; Au AY; Mochal CA; Rashmir-Raven A; Frondoza CG
Osteoarthritis Cartilage; 2010 Feb; 18(2):220-7. PubMed ID: 19748608
[TBL] [Abstract][Full Text] [Related]
20. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro.
Huang CY; Hung LF; Liang CC; Ho LJ
Eur J Clin Invest; 2009 May; 39(5):417-28. PubMed ID: 19371268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
